1. Home
  2. ADVB vs AIXI Comparison

ADVB vs AIXI Comparison

Compare ADVB & AIXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVB
  • AIXI
  • Stock Information
  • Founded
  • ADVB 2014
  • AIXI 2001
  • Country
  • ADVB United States
  • AIXI China
  • Employees
  • ADVB N/A
  • AIXI N/A
  • Industry
  • ADVB Medical Specialities
  • AIXI Computer Software: Prepackaged Software
  • Sector
  • ADVB Health Care
  • AIXI Technology
  • Exchange
  • ADVB Nasdaq
  • AIXI Nasdaq
  • Market Cap
  • ADVB 9.7M
  • AIXI 10.5M
  • IPO Year
  • ADVB 2025
  • AIXI 2023
  • Fundamental
  • Price
  • ADVB $0.42
  • AIXI $0.75
  • Analyst Decision
  • ADVB
  • AIXI
  • Analyst Count
  • ADVB 0
  • AIXI 0
  • Target Price
  • ADVB N/A
  • AIXI N/A
  • AVG Volume (30 Days)
  • ADVB 1.7M
  • AIXI 266.9K
  • Earning Date
  • ADVB 11-19-2025
  • AIXI 12-26-2025
  • Dividend Yield
  • ADVB N/A
  • AIXI N/A
  • EPS Growth
  • ADVB N/A
  • AIXI N/A
  • EPS
  • ADVB N/A
  • AIXI N/A
  • Revenue
  • ADVB N/A
  • AIXI $70,314,315.00
  • Revenue This Year
  • ADVB N/A
  • AIXI $26.84
  • Revenue Next Year
  • ADVB N/A
  • AIXI N/A
  • P/E Ratio
  • ADVB N/A
  • AIXI N/A
  • Revenue Growth
  • ADVB N/A
  • AIXI 18.84
  • 52 Week Low
  • ADVB $0.34
  • AIXI $0.60
  • 52 Week High
  • ADVB $4.10
  • AIXI $6.67
  • Technical
  • Relative Strength Index (RSI)
  • ADVB 47.63
  • AIXI 40.38
  • Support Level
  • ADVB $0.36
  • AIXI $0.65
  • Resistance Level
  • ADVB $0.49
  • AIXI $0.84
  • Average True Range (ATR)
  • ADVB 0.04
  • AIXI 0.09
  • MACD
  • ADVB -0.00
  • AIXI 0.01
  • Stochastic Oscillator
  • ADVB 44.36
  • AIXI 51.11

About ADVB Advanced Biomed Inc. Common Stock

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

About AIXI XIAO-I Corporation

XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.

Share on Social Networks: